Belite Bio (BLTE) Operating Leases (2022 - 2025)

Belite Bio has reported Operating Leases for 4 years, with the latest figure at $188000.0 in Q4 2025.

• For the quarter ending Q4 2025, Operating Leases fell 27.97% year-over-year to $188000.0; the trailing twelve-month figure through Dec 2025 stood at $188000.0 (down 27.97% YoY), and the FY2025 full-year result was $188000.0, down 27.97% from the prior year.
• Operating Leases for Q4 2025 stood at $188000.0, down from $261000.0 in the prior quarter.
• The five-year high for Operating Leases was $668000.0 in Q4 2022, with the low at $188000.0 in Q4 2025.
• Average Operating Leases over 4 years is $423750.0, with a median of $419500.0 recorded in 2023.
• Year-over-year, Operating Leases fell 13.47% in 2023 and plunged 54.84% in 2024.
• Tracing BLTE's Operating Leases over 4 years: stood at $668000.0 in 2022, then slipped by 13.47% to $578000.0 in 2023, then sank by 54.84% to $261000.0 in 2024, then decreased by 27.97% to $188000.0 in 2025.
• The last three Operating Leases figures came in at $188000.0 (Q4 2025), $261000.0 (Q4 2024), and $578000.0 (Q4 2023), per Business Quant data.

Peer Comparison